Search research articles
Contact Us
Filters
Showing results (1-10 of 56) with videos related to
Page
of 6
Sort By:
Biotechniques
|
July 10, 2010
The nuclear translocation assay for intracellular protein-protein interactions and its application to the Bcr coiled-coil domain
Andrew S Dixon, Carol S Lim
Molecular Pharmaceutics
|
April 11, 2015
Inhibition of bcr-abl in human leukemic cells with a coiled-coil protein delivered by a leukemia-specific cell-penetrating Peptide
Benjamin J Bruno, Carol S Lim
Therapeutic Delivery
|
September 6, 2012
Targeting malignant mitochondria with therapeutic peptides
Jonathan E Constance, Carol S Lim
Molecular Pharmaceutics
|
December 6, 2012
Disrupting BCR-ABL in combination with secondary leukemia-specific pathways in CML cells leads to enhanced apoptosis and decreased proliferation
David W Woessner, Carol S Lim
AAPS Pharmsci
|
November 9, 2002
Model system to study classical nuclear export signals
Charu Kanwal, Henan Li, Carol S Lim
Therapeutic Delivery
|
November 30, 2010
Controlling subcellular delivery to optimize therapeutic effect
Mohanad Mossalam, Andrew S Dixon, Carol S Lim
Molecular Pharmaceutics
|
February 13, 2013
Controlled access of p53 to the nucleus regulates its proteasomal degradation by MDM2
James R Davis, Mohanad Mossalam, Carol S Lim
Pharmaceutical Research
|
August 8, 2012
Utilizing the estrogen receptor ligand-binding domain for controlled protein translocation to the insoluble fraction
James R Davis, Mohanad Mossalam, Carol S Lim
Pharmaceutical Research
|
September 14, 2006
Controlling protein compartmentalization to overcome disease
James R Davis, Mudit Kakar, Carol S Lim
Molecular Pharmaceutics
|
December 6, 2005
Effect of initial subcellular localization of progesterone receptor on import kinetics and transcriptional activity
Henan Li, Matthew L Fidler, Carol S Lim
Page
of 6
Search research articles
Search
Showing results (1-10 of 56) with videos related to
Sort By:
Page
of 6
Biotechniques
|
July 10, 2010
The nuclear translocation assay for intracellular protein-protein interactions and its application to the Bcr coiled-coil domain
Andrew S Dixon, Carol S Lim
Molecular Pharmaceutics
|
April 11, 2015
Inhibition of bcr-abl in human leukemic cells with a coiled-coil protein delivered by a leukemia-specific cell-penetrating Peptide
Benjamin J Bruno, Carol S Lim
Therapeutic Delivery
|
September 6, 2012
Targeting malignant mitochondria with therapeutic peptides
Jonathan E Constance, Carol S Lim
Molecular Pharmaceutics
|
December 6, 2012
Disrupting BCR-ABL in combination with secondary leukemia-specific pathways in CML cells leads to enhanced apoptosis and decreased proliferation
David W Woessner, Carol S Lim
AAPS Pharmsci
|
November 9, 2002
Model system to study classical nuclear export signals
Charu Kanwal, Henan Li, Carol S Lim
Therapeutic Delivery
|
November 30, 2010
Controlling subcellular delivery to optimize therapeutic effect
Mohanad Mossalam, Andrew S Dixon, Carol S Lim
Molecular Pharmaceutics
|
February 13, 2013
Controlled access of p53 to the nucleus regulates its proteasomal degradation by MDM2
James R Davis, Mohanad Mossalam, Carol S Lim
Pharmaceutical Research
|
August 8, 2012
Utilizing the estrogen receptor ligand-binding domain for controlled protein translocation to the insoluble fraction
James R Davis, Mohanad Mossalam, Carol S Lim
Pharmaceutical Research
|
September 14, 2006
Controlling protein compartmentalization to overcome disease
James R Davis, Mudit Kakar, Carol S Lim
Molecular Pharmaceutics
|
December 6, 2005
Effect of initial subcellular localization of progesterone receptor on import kinetics and transcriptional activity
Henan Li, Matthew L Fidler, Carol S Lim
Page
of 6